Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frances A Shepherd

Showing results (101-110 of 384) with videos related to

Pageof 39
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2009
Quality-adjusted time without symptoms or toxicity analysis of adjuvant chemotherapy in non-small-cell lung cancer: an analysis of the National Cancer Institute of Canada Clinical Trials Group JBR.10 trialRaymond W Jang, Aurélie Le Maître, Keyue Ding, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2012
Adjuvant chemotherapy for non-small-cell lung cancer in the elderly: a population-based study in Ontario, CanadaSinead Cuffe, Christopher M Booth, Yingwei Peng, et al.
Thrombosis Research|May 23, 2018
Venous thromboembolism with EGFR monoclonal antibody necitumumab in stage IV non-small cell lung cancer: A retrospective cohort analysisKelvin Young, Luis Paz-Ares, Nick Thatcher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2018
Targeting the CDK4/6-Rb Pathway Enhances Response to PI3K Inhibition in <i>PIK3CA</i>-Mutant Lung Squamous Cell CarcinomaRuoshi Shi, Ming Li, Vibha Raghavan, et al.
Lung Cancer (Amsterdam, Netherlands)|February 17, 2005
Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. An analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literatureNaveed Alam, Frances A Shepherd, Timothy Winton, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 13, 2014
NCIC CTG IND.190 phase I trial of dalotuzumab (MK-0646) in combination with cisplatin and etoposide in extensive-stage small-cell lung cancerPeter M Ellis, Frances A Shepherd, Scott A Laurie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Longitudinal study of depressive symptoms in patients with metastatic gastrointestinal and lung cancerChristopher Lo, Camilla Zimmermann, Anne Rydall, et al.
Cancer|August 28, 2009
Venous thromboembolism and nonsmall cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group trialsLisa K Hicks, Matthew C Cheung, Keyue Ding, et al.
Cancers|July 26, 2020
Metabolites as Prognostic Markers for Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Platinum-Doublet ChemotherapyDesirée Hao, Arjun Sengupta, Keyue Ding, et al.
Psycho-Oncology|April 28, 2007
The contribution of attachment security and social support to depressive symptoms in patients with metastatic cancerGary Rodin, Andrew Walsh, Camilla Zimmermann, et al.
Pageof 39

Showing results (101-110 of 384) with videos related to

Sort By:
Pageof 39
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2009
Quality-adjusted time without symptoms or toxicity analysis of adjuvant chemotherapy in non-small-cell lung cancer: an analysis of the National Cancer Institute of Canada Clinical Trials Group JBR.10 trialRaymond W Jang, Aurélie Le Maître, Keyue Ding, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2012
Adjuvant chemotherapy for non-small-cell lung cancer in the elderly: a population-based study in Ontario, CanadaSinead Cuffe, Christopher M Booth, Yingwei Peng, et al.
Thrombosis Research|May 23, 2018
Venous thromboembolism with EGFR monoclonal antibody necitumumab in stage IV non-small cell lung cancer: A retrospective cohort analysisKelvin Young, Luis Paz-Ares, Nick Thatcher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2018
Targeting the CDK4/6-Rb Pathway Enhances Response to PI3K Inhibition in <i>PIK3CA</i>-Mutant Lung Squamous Cell CarcinomaRuoshi Shi, Ming Li, Vibha Raghavan, et al.
Lung Cancer (Amsterdam, Netherlands)|February 17, 2005
Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. An analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literatureNaveed Alam, Frances A Shepherd, Timothy Winton, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 13, 2014
NCIC CTG IND.190 phase I trial of dalotuzumab (MK-0646) in combination with cisplatin and etoposide in extensive-stage small-cell lung cancerPeter M Ellis, Frances A Shepherd, Scott A Laurie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Longitudinal study of depressive symptoms in patients with metastatic gastrointestinal and lung cancerChristopher Lo, Camilla Zimmermann, Anne Rydall, et al.
Cancer|August 28, 2009
Venous thromboembolism and nonsmall cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group trialsLisa K Hicks, Matthew C Cheung, Keyue Ding, et al.
Cancers|July 26, 2020
Metabolites as Prognostic Markers for Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Platinum-Doublet ChemotherapyDesirée Hao, Arjun Sengupta, Keyue Ding, et al.
Psycho-Oncology|April 28, 2007
The contribution of attachment security and social support to depressive symptoms in patients with metastatic cancerGary Rodin, Andrew Walsh, Camilla Zimmermann, et al.
Pageof 39